Antiplasmodial and antileishmanial flavonoids from Mundulea sericea

Carolyne Chepkirui,Purity J Ochieng,Biswajyoti Sarkar,Aabid Hussain,Chiranjib Pal,Li Jun Yang,Paolo Coghi,Hoseah M Akala,Solomon Derese,Albert Ndakala,Matthias Heydenreich,Vincent K W Wong,Máté Erdélyi,Abiy Yenesew,Purity J. Ochieng,Hoseah M. Akala,Vincent K.W. Wong
DOI: https://doi.org/10.1016/j.fitote.2020.104796
IF: 3.204
2021-03-01
Fitoterapia
Abstract:<p>A new flavanonol, 3-hydroxyerythrisenegalone (<strong>1</strong>), and four known compounds (<strong>2</strong>–<strong>5</strong>) were isolated from the extract of <em>Mundulea sericea</em> leaves. Investigation of the roots of this plant afforded an additional three known compounds (<strong>6–8</strong>). The structures were elucidated using NMR spectroscopic and mass spectrometric analyses. The absolute configuration of <strong>1</strong> was established using ECD spectroscopy. In an antiplasmodial activity assay, compound <strong>1</strong> showed good activity with an IC<sub>50</sub> of 2.0 μM against chloroquine-resistant W2, and 6.6 μM against the chloroquine-sensitive 3D7 strains of <em>Plasmodium falciparum</em>. Some of the compounds were also tested for antileishmanial activity. Dehydrolupinifolinol (<strong>2</strong>) and sericetin (<strong>5</strong>) were active against drug-sensitive <em>Leishmania donovani</em> (MHOM/IN/83/AG83) with IC<sub>50</sub> values of 9.0 and 5.0 μM, respectively. In a cytotoxicity assay, erythrisenegalone (<strong>3</strong>) showed significant activity on BEAS-2B (IC<sub>50</sub> 4.9 μM) and to HePG2 (IC<sub>50</sub> 10.8 μM) human cell lines. All the other compounds showed low cytotoxicity (IC<sub>50</sub> &gt; 30 μM) against human lung adenocarcinoma cells (A549), human liver cancer cells (HepG2), lung/bronchus cells (epithelial virus transformed) (BEAS-2B) and immortal human hepatocytes (LO2)</p>
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?